Evidence map›Paper›PMID 38970734›Full record

ArticleThe international journal of cardiovascular imaging2024

Mitral complex geometric changes aggravate mitral stenosis after transcatheter aortic valve replacement.

Naoko Ichikawa, Yumi Shiina, Yuina Koashi, Yuna Matsumoto, Takayoshi Kanie, Yasufumi Kijima, Hiroyuki Niinuma, Kohei Abe

Abstract read
PubMed Publisher
In one paragraph

Article in The international journal of cardiovascular imaging, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Naoko IchikawaClinical Laboratory, St. Luke's International Hospital, Tokyo, Japan.
Yumi ShiinaDepartment of Cardiology, St. Luke's International Hospital, 9-1 Akashi Chuo-ku, Tokyo, 104-8560, Japan. yushiina@luke.ac.jp.
Yuina KoashiClinical Laboratory, St. Luke's International Hospital, Tokyo, Japan.
Yuna MatsumotoClinical Laboratory, St. Luke's International Hospital, Tokyo, Japan.
Takayoshi KanieDepartment of Cardiology, St. Luke's International Hospital, 9-1 Akashi Chuo-ku, Tokyo, 104-8560, Japan.
Yasufumi KijimaDepartment of Cardiology, St. Luke's International Hospital, 9-1 Akashi Chuo-ku, Tokyo, 104-8560, Japan.
Hiroyuki NiinumaDepartment of Cardiology, St. Luke's International Hospital, 9-1 Akashi Chuo-ku, Tokyo, 104-8560, Japan.
Kohei AbeDepartment of Cardiovascular Surgery, St. Luke's International Hospital, Tokyo, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Severe aortic valve stenosis (AS) often coexists with mitral valve stenosis (MS). MS aggravation after transcatheter aortic valve replacement (TAVR) is common, and its etiology is multifactorial. We hypothesized that geometric changes in the mitral complex (mitral valvular and annular deformities) are adjunctive factors aggravating MS after TAVR, particularly in older adults with a smaller left ventricle (LV). This study aimed to evaluate the mitral complex geometric changes before and after TAVR and to assess the important predictors of MS aggravation after TAVR. This retrospective study enrolled consecutive adult patients who underwent TAVR and surgical AVR (SAVR) for severe AS. The mitral valve area (MVA), the angle between the anterior mitral valve leaflet (AMVL) and left ventricular outflow tract (LVOT), AMVL length, mitral annular diameter, presence of mitral annular calcification, and LV size were evaluated using transthoracic echocardiography. This study included 258 patients who underwent TAVR and SAVR. MVA index decreased from 2.3 ± 0.6 cm² to 1.9 ± 0.5 cm² in the TAVR group. The angle between the AMVL and LVOT was 56.3 ± 9.7° preoperatively and increased to 67.3 ± 11.5° after TAVR. In multivariate analysis, the most important predictive factors of MS aggravation after TAVR were a smaller mitral annular diameter, restricted AMVL mobility, and implantation depth (odds ratio: 4.5, 5.3,3.0; 95% confidence interval: 1.6-14, 1.9-17, 1.0-8.9; and p = 0.005, p = 0.001, p = 0.042, respectively). The reduction in MVA after TAVR was related to the restriction of AMVL opening, depth of implantation and narrowing of the mitral annulus.

Indexed as

Aortic ValveAortic Valve StenosisMitral ValveMitral Valve StenosisSeverity of Illness IndexTranscatheter Aortic Valve ReplacementAgedAged, 80 and overFemaleHeart Valve ProsthesisHumansMaleRetrospective StudiesRisk FactorsTime FactorsTreatment OutcomeAortic valve stenosisEchocardiographyMitral complex geometric changesMitral valve stenosisTranscatheter aortic valve replacement

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.